Stay informed with the latest litigation news. Explore now

IP Verse

Pharmaceutical Compositions For Inhalation - EP2298279B1

EP2298279

VECTURA
Application Number
EP10182218A
Filing Date
Nov 30, 2001
Status
Revoked
Nov 24, 2023
Grant Date
Nov 14, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4061453B1
EP3613421B1
EP3179986B1

Bibliography

The patent EP2298279B1 was granted to Vectura on Nov 14, 2018 following the initial filing on Nov 30, 2001 under the application number EP10182218A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXO GROUPAug 12, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents